Pre-made Tomaralimab benchmark antibody ( Whole mAb, anti-TLR2 therapeutic antibody, Anti-CD282/TIL4 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Tomaralimab biosimilar, Whole mAb, Anti-TLR2 Antibody: Anti-CD282/TIL4 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	List Price(In USD)	Discount off	Discount Price
GMP-Bios-ab-585-1mg	1mg	3090	Inquiry	Inquiry

Size： 1mg | 10mg | 100mg

Description

Products Name (INN Index)	Pre-Made Tomaralimab biosimilar, Whole mAb, Anti-TLR2 Antibody: Anti-CD282/TIL4 therapeutic antibody
INN Name	Tomaralimab
Target	TLR2
Format	Whole mAb
Derivation
Species Reactivity	Human
CH1 Isotype	IgG4
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Phase-II
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2018
Year Recommended	2019
Companies	Opsona Therapeutics
Conditions Approved	na
Conditions Active	Delayed graft function;Myelodysplastic syndromes;Cancer
Conditions Discontinued	Autoimmune disorders;Inflammation
Development Tech	na